Skip to main content

Find Clinical Trials

Home
Conditions
Myelitis

Clinical trial condition

Myelitis

Explore clinical trials studying Myelitis. Study availability and eligibility vary by location and protocol.

284 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Myelitis trial results

Completed

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

NCT01323959

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations: GSK Investigational Site Derval, France

GSK Investigational Site La Chapelle-Basse-Mer, France

GSK Investigational Site La Riche, France

GSK Investigational Site Nantes, France

View all 15 locations

View Trial Details

Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations: GSK Investigational Site Genoa, Liguria, Italy

GSK Investigational Site Milan, Lombardy, Italy

GSK Investigational Site Novara, Piedmont, Italy

GSK Investigational Site Cagliari, Sardinia, Italy

View Trial Details

Completed

Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine

NCT00325143

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Singapore

View Trial Details

Completed

Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)

NCT00964028

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: GSK Investigational Site Wuzhou, Guangxi, China

View Trial Details

Completed

Enhance Wellness for Individuals With Long-Term Physical Disabilities

NCT02815878

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +30 more
Locations: University of Washington Seattle, Washington, United States

View Trial Details

Completed

IPV Clinical Trial - The Gambia

NCT01847872

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Medical Research Council Unit Fajara, The Gambia

View Trial Details

Completed

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

NCT00432042

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +53 more
Locations: Alsfeld, Germany

Bad Saulgau, Germany

Bad Säckingen, Germany

Bad Sobernheim, Germany

View all 50 locations

View Trial Details

Completed

Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine

NCT02643368

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: International Center for Diarrhoeal Disease Research, Bangladesh Dhaka, Bangladesh

View Trial Details

Completed

Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers

NCT00920439

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: GSK Investigational Site Wuzhou, Guangxi, China

View Trial Details

Completed

ID Administration of fIPV Using Intradermal Adapters vs. BCG Syringe

NCT02769923

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +11 more
Locations: Not specified

View Trial Details